Infusion Pump Market Current Progress, Growth Drivers, challenges, and Future Development

 Infusion Pump Market growth is driven by a rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed. However, factors such as product recalls, stringent regulatory requirements for new products and increasing adoption of refurbished and rental infusion pumps may restrain market growth to a certain extent during the forecast period.

Currently, Infusion Pump Market is growing at a Compound Annual Growth Rate (CAGR) of 7.0% to reach USD 20.5 billion by 2027. An infusion system consists of a pump (device) and associated disposables for delivering fluids, such as nutrients and medications, into a patient’s body in controlled amounts. These devices are efficiently used for infusion through several routes of administration, such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral, and intrathecal. They enable the delivery of solutions in a predetermined and controlled manner and are thus helpful in managing chronic diseases and associated pain.

Request for assumptions & how numbers were triangulated. 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506

 

Growth Drivers

• Rising demand for ambulatory infusion pumps in home care settings
• Increasing incidence of chronic diseases along with rapid growth in geriatric population
• Growing number of surgical procedures performed

Growth Opportunities

• High growth opportunities in emerging countries
• Growing adoption of specialty infusion systems

Challenges

• Increasing incidence of medication errors and lack of wireless connectivity in most hospitals

Trends

• Smart pump-emr interoperability
• Growing focus on development of hybrid closed-loop systems/artificial pancreas device systems.
• Growing focus on specialty pumps and added advanced features.

 

The prominent players operating in the Infusion Pump Market are

 

Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), ICU Medical (US), Fresenius Kabi (Germany), and Medtronic plc (Ireland),

 

Download an Illustrative Overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506

 

North America is expected to exhibit the highest growth during the forecast period

• Increasing prevalence of chronic diseases such as obesity, heart disease, diabetes, and other chronic diseases
• Rising geriatric population,
• Increasing investment by major market players

Recent Developments

• In August 2022, Baxter International (US) has received US FDA approval for the new Novum IQ Syringe Infusion Pump (SYR) with Dose IQ Safety Software.
• In July 2022, Tandem Diabetes care (US) has acquired infusion set developer, Capillary Biomedical (US). This has expanded the product portfolio of Tandem Diabetes Care in infusion pump business segment.
• In March 2022, Fresenius Kabi (Germany) has received US FDA approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology.

 

Revolutionizing the Pharmaceutical Industry: An Insight into the Growing Pharmaceutical Packaging Equipment Market

 Pharmaceutical Packaging Equipment Market growth is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, the introduction of regulatory standards on the packaging, and stringent norms against counterfeiting. However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a certain extent during the forecast period.

Currently, Pharmaceutical Packaging Equipment Market is growing at a Compound Annual Growth Rate (CAGR) of 7.2 % to reach USD 11.9 billion by 2027. The primary packaging equipment segment accounted for the largest share of the global pharmaceutical packaging equipment market in 2021. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and the sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment.

Request for Sample pages https://www.marketsandmarkets.com/requestsampleNew.asp?id=19845828

 

Growth Drivers

• High growth in generics & biopharmaceuticals markets
• Growing need for flexible and integrated packaging equipment
• Increase in offshore pharmaceutical manufacturing
• Growing contract manufacturing of pharmaceutical products
• Introduction of regulatory standards on packaging and stringent norms against counterfeit products
• Innovation in pharmaceutical packaging and delivery system
• Growth in OTC drug sales and regulations to reduce OTC counterfeit

Growth Opportunities

• Growth of pharmaceutical manufacturing in emerging economies
• Rising demand for automated packaging
• Change in medication systems to self-medication and self-care
• Increasing pharmaceutical R&D investments

Challenges

• Growth in personalized and precision medicine supply chain
• Uncertainties in regulations and standards of the pharmaceutical packaging process

Trends

• Development of production lines for small batch sizes and research purposes
• Automation and integration of packaging equipment
• Growing focus on labeling and serialization for anti-counterfeiting of drugs
• Growing demand for aseptic filling and sealing equipment

 

The prominent players operating in the Pharmaceutical Packaging Equipment Market are

 

Robert Bosch GmbH (Syntegon Technology GmbH) (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Coesia S.p.A (Italy), and Marchesini Group S.p.A (Italy).

Download an Illustrative Overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

 

Europe is expected to exhibit the highest growth during the forecast period

• High pharmaceutical production,
• Increasing demand for flexible packaging equipment by major pharmaceutical manufacturers,
• Rising focus on product diversification by companies

 

Surge in Demand for Surgical Robots to Drive Market Growth to $14.4 billion by 2026

 The surgical robots market report from MarketsandMarkets provides analysis and forecast information for the Surgical robots market, broken down by product, application, and geography. The report includes market size and forecast data for various segments of the market, as well as market share analysis for key players in the industry. Additionally, the report includes market dynamics such as drivers, restraints, and opportunities, as well as an in-depth analysis of the competitive landscape. Overall, the report provides a comprehensive overview of the surgical robots market and can be a valuable resource for industry professionals and investors.

The global Surgical robots market is projected to reach USD 14.4 billion by 2026 from USD 6.4 billion in 2021, growing at a CAGR of 17.6%

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

The surgical robots market is expected to grow at a significant rate during the forecast period. This growth is driven by factors such as increasing adoption of minimally invasive surgeries, growing geriatric population and corresponding increase in chronic diseases, and rising investment in healthcare infrastructure. Additionally, technological advancements in surgical robots and increasing collaboration between companies and academic institutes are also expected to drive market growth. However, high cost of surgical robots and lack of skilled professionals may restrain the growth of the market.

The surgical robots market is segmented by product, application, and geography. By product, the market is segmented into robotic systems, instruments and accessories, and services. By application, the market is segmented into general surgery, gynecology, urology, orthopedic, and others. And by geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR  Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan).

Flow Cytometry Market Growth Drivers & Opportunities | MarketsandMarkets

 Flow Cytometry Market is projected to grow from USD 4.7 billion in 2022 to USD 6.9 billion by 2027, at a CAGR of 8.1% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of the Flow Cytometry Market is largely driven by the rising prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research activities, increasing public-private initiatives in immunology and immuno-oncology research, and rising technological advancements in flow cytometry software.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Browse in-depth TOC on "Flow Cytometry Market"

331 – Tables
37 – Figures
332 – Pages

Reagents & consumables segment held major share in Flow Cytometry Market in 2021.

Based on product & service, the market is segmented into reagents & consumables, instruments, software, services, and accessories. Reagents & consumables accounted for the largest share in the market in 2021. The large share of this segment can primarily be attributed to the growing use of flow cytometry techniques in clinical & research applications.

Research application segment dominated the global Flow Cytometry Market in 2021.

Based on applications, the market is segmented into research, clinical, and industrial applications.  In 2021, the research applications segment accounted for the largest share in the global market.  The large share of the research applications segment is mainly due to the growing adoption of flow cytometry in research activities and the increasing availability of flow cytometry services, such as cell sorting, cell cycle analysis, and apoptosis.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584

North America has registered fastest growth rate during the forecast period in Flow Cytometry Market

Geographically, the Flow Cytometry Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share in the global market in 2021. The large share of North America in the market is largely driven by the presence of key market players and increasing public-private initiatives for research activities. The market in the Asia Pacific region is expected to grow at the highest CAGR of 8.6% during the forecast period. The high growth rate of the APAC region can be attributed to the growing pharmaceutical industry; increasing participation of emerging markets in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiatives to boost advanced proteomics research in the region.

The prominent players in the Flow Cytometry Market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the market.

Catheters Market - Growth Drivers & Opportunities | MarketsandMarkets

 The growing target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery are the major factors driving the growth of catheters market.

The global catheters market is projected to reach USD 24.2 billion by 2025 from USD 15.9 billion in 2020, at a CAGR of 8.7%. 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6247803

Market Segmentation: -

On the basis of type, the global catheters market is segmented broadly into cardiovascular, urological, intravenous, neurovascular, and specialty catheters. Cardiovascular catheters commanded the largest share of the catheters market in 2019 and are expected to grow at the highest CAGR during the forecast period. This is primarily attributed to factors such as the high incidence of CVD, the growing geriatric population, and increasing awareness regarding early diagnosis. These factors have resulted in an increase in cardiovascular surgeries, which positively impacts the cardiovascular catheters market.

Based on end user, the catheters market is segmented into hospitals, long-term care facilities, diagnostic imaging centers, and other end users. In 2019, hospitals were the largest end users of catheters. This segment is expected to grow at the highest CAGR, majorly due to the high volume of target procedures performed in hospitals. The presence of big cath labs and electrophysiology labs in hospitals and a growing patient population are other key drivers of this market. The emergence of advanced diagnostic imaging catheters, coupled with the demand for minimally invasive procedures, is accelerating the adoption of catheters in hospitals.

Regional Analysis:

The catheters market has been divided into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global catheters market in 2019. This is attributed to various factors such as the large number of target procedures performed in the region, the presence of a well-established healthcare system, and investments by hospitals to upgrade & expand operating capabilities.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=6247803

Top Key Players:

The prominent players operating in this market include Medtronic (Ireland), Edwards Lifesciences Corporation (US), Teleflex Incorporated (US), Abbott (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), ConvaTec Group (UK), Coloplast (Denmark), Johnson & Johnson Services (US), Terumo Corporation (Japan), Hollister Incorporated (US), Stryker (US), Cook Medical (US), and Merit Medical Systems (US).

 

European Medical Devices Market Growth Drivers & Opportunities | MarketsandMarkets

 Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. The base year considered for the study is 2019, while the forecast period is 2020 to 2025.

The report European Medical Devices Market  is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241277169

Market Segmentation: -

By device, orthopedic devices segment accounted for the largest share of the European Medical Device Market in 2019

Based on device type, the market has been segmented into orthopedic devices, diagnostic imaging systems, endoscopy devices, ophthalmic devices, interventional cardiology devices, cardiac monitoring and cardiac rhythm management devices, respiratory care devices, ventilators, anesthesia monitoring devices, dialysis devices, and diabetic care devices. The orthopedic devices segment accounted for the largest share of the European medical devices market in 2019. The growing incidence of orthopedic disorders such as arthritis, osteoporosis, soft-tissue injuries, and fractures among the elderly population is expected to drive the demand for orthopedic devices in Europe.

The Hospitals and clinical care settings segment is expected to witness the highest growth rate in the European medical devices market, by end-user, during the forecast period

Based on end-user, the European medical devices market is segmented into hospitals and clinical care settings and home care settings. Hospitals and clinical care settings were the largest end-users of medical devices in Europe in 2019. This can largely be attributed to the financial capabilities of hospitals to purchase expensive devices as well as the availability of trained professionals in hospitals to operate these devices.

Regional Analysis: -

Germany accounted for the largest share of the European medical device market in 2019. The rising geriatric population and the presence of strong healthcare infrastructure in the country are the major factors that are driving the demand for medical devices in Germany.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=241277169

Key Market Players: -

The prominent players in the global European medical device market are Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Abbott (US), Medtronic (Ireland), Stryker (US), Boston Scientific (US), Asahi Kasei Medical (Japan), B. Braun (Germany),  Baxter International, Inc. (US), ResMed (US), Masimo (US), and KARL STORZ (Germany)..

Hologic, Inc. and Danaher Corporation are Leading Players in the Breast Biopsy Market

 The factors driving the growth of the market are growing incidence of breast cancer, improved reimbursement scenario, and increased awareness of early detection of breast cancer. However, risk of infections associated with the use of biopsy needles and stringent regulatory approval procedures are expected to restrain the growth of this market in the coming years.

The breast biopsy market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.

Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805

 

In 2019, the breast biopsy market was dominated by Hologic, Inc. (US), Danaher Corporation (US), Becton, Dickinson and Company (US), QIAGEN (Netherlands), and Illumina, Inc. (US). The players adopted key strategies, such as, new product launches, mergers and acquisition, high R&D investment to increase their market penetration.

Hologic, Inc. (US) holds the leading position in the breast biopsy market, owing to its robust portfolio of breast biopsy products and related accessories. The company has expanded its product portfolio through insight-driven innovation and product launches to establish its position in the market. For instance, during the last three years, Hologic launched the Brevera Breast Biopsy System with CorLumina Imaging Technology in the US and Europe, which are the leading markets for breast biopsy. Hologic is expected to witness sustainable growth during the forecast period with its broad and technologically advanced product portfolio, wide geographic reach, and high product promotional activities.

Owing to the strong focus on R&D and new product developments, QIAGEN (Netherlands) has established itself as a leading player in the liquid breast biopsy market segment. The company’s large market share is attributed to its broad portfolio of products and its vast geographical presence across 130 countries. Strong R&D activities have enabled the company to deliver novel products in the market. New product launches and approvals will further increase its penetration in the liquid breast biopsy segment. For instance, during the last three years, QIAGEN received US FDA and CE mark approvals for its Therascreen PIK3CA RGQ PCR Kit; and launched the RNeasy Midi and Maxi Kits and miRNeasy 96 Advanced QIAcube HT Kit.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805

 

However, in May 2020, Thermo Fisher Scientific acquired Qiagen for USD 11.5 billion. This acquisition has expanded Thermo Fisher’s infectious diseases, cancer, and genetic disorders product portfolio. Thermo Fisher Scientific is expected to emerge as a leader in the liquid biopsy market 2020 onwards.

 

Genomics Market - Global Growth Drivers & Opportunities | MarketsandMarkets

 "Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025", published by MarketsandMarkets™, the global Genomics Market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19.0% during the forecast period.

Browse in-depth TOC on "Genomics Market"

114 – Tables
34 – Figures
194 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613

Scope of the Report:

The study categorizes the market into the following segments and subsegments:

By Product & Service

• Systems & Software
• Consumables
• Services

By Technology

• Sequencing
• PCR
• Nucleic Acid Extraction and Purification
• Microarray
• Other Technologies

By Application 

• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other Applications

By End User

•  Hospitals & Clinics  
• Research Centers and Academic & Government Institutes,
• Pharmaceutical & Biotechnology Companies
• Other End Users

By Region

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• The Middle East and Africa

The major factors driving the growth of this market include the increasing government funding to support genomics projects, the growing incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups in the genomics product and service market, and the growing application areas of genomics.

The next generation sequencing sub segment accounted for the largest share of the sequencing technology segment in the genomics market in 2019.

Based on technology, the market is segmented into sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies. The sequencing segment is further sub segmented into next-generation sequencing (NGS) and other sequencing technologies. In 2019 the next-generation sequencing technology accounted for the largest share of the genomics market. The advantages associated with NGS such as ultra-high-throughput, scalability, and high speed, enable researchers to perform a wide variety of applications, including animal breeding, agriculture, and human genomics. This is one of the major drivers of this segment.

The hospitals and clinics segment accounted for the largest share of the end user segment in the genomics product and service market in 2019.

Based on end users, the genomics market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users. In 2019, the hospitals & clinics segment accounted for the largest share of the market. Hospitals & clinics are shifting from traditional genomic testing methods to cost-effective and more sensitive methods, such as whole-exome sequencing, which is a major factor driving the market growth.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=613

The Asia Pacific region is the fastest growing region of the genomics market in 2019.

In 2019, the Asia Pacific region accented for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the genomics product and service market during the forecast period, mainly due to favorable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, and expansions of key players to strengthen their presence in the APAC region.

Some of the leading players operating in the genomics product and service market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and BGI (China).

Veterinary Antimicrobial Susceptibility Testing Market worth $135 million by 2026 - Exclusive Report by MarketsandMarkets™

 "Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry),End User (Veterinary Reference Labs, Universities) - Global Forecast to 2026", published by MarketsandMarkets™, the Veterinary AST Market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%.

Browse in-depth TOC on "Veterinary Antimicrobial Susceptibility Testing Market"
169 – Tables
62 – Figures
227 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50401056

Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies. The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players. On the other hand, the high cost of automated veterinary AST systems and rising pet care costs are expected to restrain the overall market growth to a certain extent.

Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

The food-producing animal segment is expected to account for the largest share of the veterinary AST market

Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market in 2020. The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals. This segment is further categorized into cattle, pigs, poultry, and other food-producing animals. Companion animals are further segmented into dogs, cats, horses, and other companion animals.

The culture media segment is expected to grow at the highest rate during the forecast period

The culture media segment is expected to register the highest growth rate during the forecast period. Growth in this product segment can be attributed to the constant requirement and recurrent purchase of these products for cultivating bacterial isolates under controlled environmental laboratory conditions.

The veterinary reference laboratory end-user segment is expected to account for the largest share of the veterinary AST market

Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users. Veterinary reference laboratories accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the large number of samples received for AST in reference laboratories from small and large animal practices. This segment is also expected to register the highest growth during the forecast period (2021–2026).

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=50401056

Asia Pacific is expected to account for the highest CAGR for players operating in the veterinary AST market

The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in pet adoption, increasing awareness about animal health, and the growing per capita animal health expenditure, especially in India and China, contribute to the growth of the APAC antimicrobial susceptibility testing market.

Some of the major players in the veterinary antimicrobial susceptibility testing market include Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Bruker Corporation (US), bioMérieux SA (France), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S (Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK), Hardy Diagnostics (US), and Liofilchem Srl (Italy).